Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Update of the EORTC QLQ-Ovarial Cancer Module (EORTC-QLQ-OV28) - OV39 Phase III

NCT07465133 is registered in ClinicalTrials.gov with Helios University Hospital Wuppertal as lead sponsor.

NCT NCT07465133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07465133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Update of the EORTC QLQ-Ovarial Cancer Module (EORTC-QLQ-OV28) - OV39 Phase III
Lead sponsor
Helios University Hospital Wuppertal
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
December 31, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, quality of life